Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeNon-Current Debt
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CureVac N.V (CVAC) Cash from Operations: 2020-2025

Historic Cash from Operations for CureVac N.V (CVAC) over the last 4 years, with Jun 2025 value amounting to -$47.6 million.

  • CureVac N.V's Cash from Operations rose 50.39% to -$47.6 million in Q2 2025 from the same period last year, while for Jun 2025 it was $226.6 million, marking a year-over-year increase of 172.23%. This contributed to the annual value of $108.8 million for FY2024, which is 137.76% up from last year.
  • CureVac N.V's Cash from Operations amounted to -$47.6 million in Q2 2025, which was down 9.40% from -$43.5 million recorded in Q1 2025.
  • In the past 5 years, CureVac N.V's Cash from Operations ranged from a high of $628.4 billion in Q4 2021 and a low of -$330.8 billion during Q2 2021.
  • Moreover, its 3-year median value for Cash from Operations was -$67.9 million (2023), whereas its average is -$26.4 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first spiked by 119,301.21% in 2021, then plummeted by 64,537.94% in 2022.
  • Quarterly analysis of 5 years shows CureVac N.V's Cash from Operations stood at $628.4 billion in 2021, then plummeted by 100.01% to -$50.1 million in 2022, then increased by 6.32% to -$46.9 million in 2023, then crashed by 51.61% to -$71.1 million in 2024, then soared by 50.39% to -$47.6 million in 2025.
  • Its last three reported values are -$47.6 million in Q2 2025, -$43.5 million for Q1 2025, and -$71.1 million during Q4 2024.